Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 28 of PharmaCyte Biotech, Inc.'s SEC filings and found 6 warrant series, 2 convertibles, 2 shelf registrations and 1 completed offering on file for PMCB. The latest dilution event on file is a registration statement on Sep 26, 2025. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
LIMNLiminatus Pharma, Inc. Class A Common Stock
DRMADermata Therapeutics, Inc.
APVOAptevo Therapeutics Inc.
KALAKALA BIO, Inc.
ERNAErnexa Therapeutics Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
GRIGRI Bio, Inc.
JUNSJupiter Neurosciences, Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
CMNDClearmind Medicine Inc.
HLSQTessera Defense and Homeland Security Inc
APUSApimeds Pharmaceuticals US, Inc
MDCXMedicus Pharma Ltd. Common Stock
REVBRevelation Biosciences, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs